132 related articles for article (PubMed ID: 7984269)
21. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
[TBL] [Abstract][Full Text] [Related]
22. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia.
Zuideveld KP; Treijtel N; Maas HJ; Gubbens-Stibbe JM; Peletier LA; van Der Graaf PH; Danhof M
J Pharmacol Exp Ther; 2002 Jan; 300(1):330-8. PubMed ID: 11752133
[TBL] [Abstract][Full Text] [Related]
23. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
[TBL] [Abstract][Full Text] [Related]
24. The relation of central 5-HT1A and 5-HT2 receptors: low dose agonist-induced selective tolerance in the rat.
Pranzatelli MR; Pluchino RS
Pharmacol Biochem Behav; 1991 Jun; 39(2):407-13. PubMed ID: 1835098
[TBL] [Abstract][Full Text] [Related]
25. 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression.
Shayit M; Yadid G; Overstreet DH; Weller A
Brain Res; 2003 Aug; 980(1):100-8. PubMed ID: 12865163
[TBL] [Abstract][Full Text] [Related]
26. Desensitization of 5-HT1A autoreceptors by chronic administration of 8-OH-DPAT.
Kreiss DS; Lucki I
Neuropharmacology; 1992 Oct; 31(10):1073-6. PubMed ID: 1436390
[TBL] [Abstract][Full Text] [Related]
27. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
28. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
Clarke RW; Ogilvie J; Houghton AK
Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
[TBL] [Abstract][Full Text] [Related]
29. Modulation of the behavioral effects of 8-OH-DPAT by estrogen and DOI.
Maswood N; Uphouse L
Pharmacol Biochem Behav; 1997 Dec; 58(4):859-66. PubMed ID: 9408187
[TBL] [Abstract][Full Text] [Related]
30. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
[TBL] [Abstract][Full Text] [Related]
31. Effects of cold stress on some 5-HT1A, 5-HT1C and 5-HT2 receptor-mediated responses.
Zamfir O; Broqua P; Baudrie V; Chaouloff F
Eur J Pharmacol; 1992 Aug; 219(2):261-9. PubMed ID: 1385172
[TBL] [Abstract][Full Text] [Related]
32. Effects of the serotonin1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin on neurochemical responses to stress.
Saphier D; Welch JE
J Neurochem; 1995 Feb; 64(2):767-76. PubMed ID: 7530293
[TBL] [Abstract][Full Text] [Related]
33. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
Vicentic A; Li Q; Battaglia G; Van de Kar LD
Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
[TBL] [Abstract][Full Text] [Related]
34. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
Yu H; Liu Y; Hacksell U; Lewander T
Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
[TBL] [Abstract][Full Text] [Related]
35. Effects of galanin on 8-OH-DPAT induced decrease in body temperature and brain 5-hydroxytryptamine metabolism in the mouse.
Patel S; Hutson PH
Eur J Pharmacol; 1996 Dec; 317(2-3):197-204. PubMed ID: 8997601
[TBL] [Abstract][Full Text] [Related]
36. Holtzman and Harlan Sprague-Dawley rats: differences in DRL 72-sec performance and 8-hydroxy-di-propylamino tetralin-induced hypothermia.
Balcells-Olivero M; Cousins MS; Seiden LS
J Pharmacol Exp Ther; 1998 Aug; 286(2):742-52. PubMed ID: 9694929
[TBL] [Abstract][Full Text] [Related]
37. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
38. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029
[TBL] [Abstract][Full Text] [Related]
39. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
Scott PA; Chou JM; Tang H; Frazer A
J Pharmacol Exp Ther; 1994 Jul; 270(1):198-208. PubMed ID: 8035316
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT.
Deprés-Brummer P; Metzger G; Lévi F
Eur J Pharmacol; 1998 Apr; 347(1):57-66. PubMed ID: 9650848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
